Trademark: 79330693
Word
ENFINIT PLATFORM FOR CAR-T
Status Date
Tuesday, January 9, 2024
Filing Date
Tuesday, September 14, 2021
40 Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacturing of antigens, antibodies, T-cells; Providing medical information relating to immunotherapy; information, advice and consulting services related to the field of pharmaceutical products manufacturing
5 Pharmaceutical products for use in the fields of oncology and immunotherapy; biological and pharmaceutical preparations for treatment of cancer and tumors; biological and pharmaceutical preparations for treating cancer and tumors using immunotherapy; preparing therapeutic preparations being solutions, namely, antigen, antibodies, T-cells in the nature of preparations for treatment of cancer and tumors; biological materials, preparations, reagents being pharmaceutical for products for medical use in the treatment of cancer and tumors; pharmaceutical antigens, antibodies, and cells for therapeutic use
1 Biological and chemical preparations for use in the pharmaceutical industry and research; chemical reagents for the manufacture of therapeutic immunotherapy solutions
44 Providing medical information relating to immunotherapy
42 Scientific research services, namely medical research; scientific research and product development, namely, identifying, screening and developing antigens; scientific and technological services, namely, scientific research, analysis and testing in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information on immunotherapy; providing scientific research services for identifying, analyzing, authenticating, purifying and developing biological material from a genomic platform; scientific analysis, namely, epigenetic antigen screening and identification services for therapeutic research purposes; scientific research, namely, genomic and epigenetic characterization services for identifying drug candidates in immunotherapy; designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for analyzing cells, antigens, tissue, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of online non-downloadable computer software platforms enabling the use of algorithms for forecasting the characteristics of antigens and immunological responses
Jan 9, 2024
Report Completed Suspension Check Case Still Suspended
Jul 12, 2023
Report Completed Suspension Check Case Still Suspended
Apr 11, 2023
Attorney Review Completed
Apr 11, 2023
Correction From Ib Entered - Attorney Review Required
Mar 5, 2023
Uspto Correction Processed By Ib
Mar 5, 2023
Uspto Correction Processed By Ib
Mar 5, 2023
Correction Transaction Received From Ib
Jan 9, 2023
Notification Of Letter Of Suspension E-Mailed
Jan 9, 2023
Letter Of Suspension E-Mailed
Jan 9, 2023
Suspension Letter Written
Jan 6, 2023
Teas Change Of Correspondence Received
Jan 6, 2023
Teas Change Of Domestic Representatives Address
Jan 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 6, 2023
Teas/Email Correspondence Entered
Jan 5, 2023
Correspondence Received In Law Office
Jan 5, 2023
Teas Response To Office Action Received
Dec 12, 2022
Correction Sent To Ib
Dec 12, 2022
Correction Sent To Ib
Dec 7, 2022
Correction Created For Ib
Dec 7, 2022
Correction Created For Ib
Jul 26, 2022
Refusal Processed By Ib
Jul 6, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 6, 2022
Refusal Processed By Mpu
Jun 18, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 17, 2022
Non-Final Action Written
Jun 17, 2022
Assigned To Examiner
Jan 11, 2022
Application Filing Receipt Mailed
Jan 7, 2022
New Application Office Supplied Data Entered
Jan 6, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
